Target intelligence / Profile preview

ribosomal protein L7a pseudogene 31 (RPL7AP31)

Target: RPL7AP31
Molecular classification: Other (Processed pseudogene)

Overview

ribosomal protein L7a pseudogene 31 (RPL7AP31) is a processed pseudogene related to the ribosomal protein L7a gene (RPL7A), which encodes a component of the 60S ribosomal subunit involved in protein synthesis[6][9]. Pseudogenes such as RPL7AP31 are non-functional copies of genes that arise due to genetic duplication or retrotransposition and typically do not produce functional proteins. RPL7AP31 has no known protein product, biological function, or role in disease or drug targeting. It serves primarily as a genomic relic without a proven impact on health or therapeutics[6][9].

Other names: RPL7A_7_480RPL7AP31

Beyond the preview

Go deeper on ribosomal protein L7a pseudogene 31 (RPL7AP31).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ribosomal protein L7a pseudogene 31 (RPL7AP31).

Explore the full profile